4th Annual UT Southwestern Neurotherapeutics Update

Dallas, TX US
November 3, 2018

The 4th Annual UTSW Neurotherapeutics Update CME live activity wlll provide a review and update in key areas of clinical neurology.  Emphasis will be placed on updates in diagnosis, management, and the most current treatment modalities that have practical applications for neurologists, other clinicians, and health care professionals.

Target Audience

This CME activity is designed for Physicians, Advanced Practice Nurses, Physician Assistants, Registered Nurses, Physical Therapists, Allied Health Professionals, and other healthcare professionals that specialize in neuroscience and neurotherapeutics, who are interested in learning about the most current treatment modalities and best management practices, in order to improve patient care and health outcomes.

Learning Objectives

Upon completion of this course, participants shall be able to:

  • Investigate best options for diagnosis, pharmacological and surgical management of facial pain.
  • Explain diagnostic approach as well as surgical and non-surgical management of spine disease.
  • Interpret latest updates in diagnosis and treatment modalities to improve long-term disability outcomes in stroke patients.
  • Explore and implement novel management approaches in treating MS patient to improve long-term mobility.
  • Investigate the latest diagnostic options in accurately diagnosing patients with dizziness.
  • Identify Psychogenic Movement Disorders (PMDs) and implement effective multi-disciplinary treatment options.
  • Evaluate clinical trials of novel agents in migraine treatment along with safety/tolerability data, pharmacokinetics and mechanism of action.
  • Differentiate and treat different forms of rapidly progressive dementias based on new diagnostic criteria.
  • Assess the efficacy and safety of new treatments and medications available for managing neuromuscular disorders.
  • Evaluate what effects pregnancy, menstruation, oral contraception have on epilepsy and how these states influence anti-epileptic drugs.
Course summary
Available credit: 
  • 7.00 AMA
  • 7.00 Attendance
Course opens: 
07/16/2018
Course expires: 
11/03/2019
Event starts: 
11/03/2018 - 7:00am
Event ends: 
11/03/2018 - 4:30pm
Cost:
$100.00
Rating: 
0
T. Boone Pickens Biomedical Building Auditorium
6001 Forest Park Road
Dallas, TX 75235
United States

Course Directors

Jaya Trivedi, MD, FAAN, FANA
Professor
Department of Neurology and Neurotherapeutics

Steven Vernino, MD, PhD
Professor
Department of Neurology and Neurotherapeutics

Accreditation

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The University of Texas Southwestern Medical Center designates this continuing education activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Available Credit

  • 7.00 AMA
  • 7.00 Attendance

Accreditation Period

Course opens: 
07/16/2018
Course expires: 
11/03/2019

Price

Cost:
$100.00
Please login or create an account to take this course.

Registration

To register:

  1. Create an account in EthosCE, online learning management system, by selecting the "create an account" link or "login" to your existing account.
  2. Return to this course page, select the designated fee and click the "add to cart" button.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.

Refund Policy

A $25 handling fee will be deducted from all cancellation refunds.  Refund requests must be received by email or fax prior to October 20, 2018.  No refund will be made thereafter.  Registrations are non-transferable.